Duchenne muscular dystrophy -DMD Ppts and Latest 50 Published artilces

Duchenne muscular dystrophy is an inherited disorder that involves rapidly worsening muscle weakness. Duchenne muscular dystrophy (DMD) is a recessive X-linked form of muscular dystrophy, which results in muscle degeneration, difficulty walking, breathing, and death.


Duchenne  Muscular Dystrophy
by Curtis Kendall
http://vgn.uvm.edu/outreach/data/Bio-UVM-fall-2006/Duchenne%20Muscular%20Dystrophy.ppt

Duchenne’s  Muscular Dystrophy: A Multidisciplinary Approach
By: Brittany  Annis
http://eportfolios.ithaca.edu/bannis1/docs/dmdinservice.ppt

Duchenne  Muscular Dystrophy
https://cstl-hhs.semo.edu/dhbeard/pe408/protected/MUSCULAR%20DYSTROPHY.ppt

Neuromuscular Disorders
by Dwayne McClerklin, MD
http://clinicaldepartments.musc.edu/anesthesia/intranet/education/interactive_learning/CA1/files/Neuromusculardisease.ppt

Duchenne  Muscular Dystrophy and Utrophin
by Iona Ross
http://www.ele.uri.edu/courses/bme281/F11/IonaR_2.ppt

Duchenne Muscular Dystrophy
by: Melissa  Martinez & Mando Aguero
http://www.laredo.edu/science/rviswanath/BIOL2401PPT/Duchenne%20MD.ppt

Finding Disease  Genes
http://www.bios.niu.edu/johns/humgen/Finding_Disease_Genes.ppt

Dystrophin and the Extracellular Matrix
by Eric Niederhoffer
http://www.siumed.edu/~eniederhoffer/som_pbl/SSB/powerpoint/dystrophin_ecm.ppt

Study Guide/Outline—RNA  Processing
http://science.kennesaw.edu/~echen1/Genetics/Quarter%204--Brooker/RNA-processing.ppt

Musculoskeletal Common MS disorders in Children
http://www2.sunysuffolk.edu/shaffec/Student%20PP%202011/Musculoskeletal%202012%20Student%20Version.ppt

Muscular System: Histology and Physiology
http://www.cerritos.edu/charbut/AP150/lec_otl/150%20Ch9-Muscle.ppt

Muscular Dystrophy
http://filer.case.edu/users/pxm73/Muscular%20Dystrophy.ppt

Latest 50 Published artilces

1. A longitudinal cause-of-death analysis of patients with Duchenne muscular dystrophy].
2. [Duchenne muscular dystrophy.
3. [Hematopoietic prostaglandin d synthase inhibitors for the treatment of duchenne muscular dystrophy].
4. [Relationship between gene mutations and intelligence in children with Duchenne muscular dystrophy].
5. [Therapeutic readthrough strategy for suppression of nonsense mutations in duchenne muscular dystrophy].
6. [Treatment for neuromuscular scoliosis in duchenne muscular dystrophy].
7. 14.1 T whole body MRI for detection of mesoangioblast stem cells in a murine model of Duchenne muscular dystrophy.
8. A Simplified Immune Suppression Scheme Leads to Persistent Micro-dystrophin Expression in Duchenne Muscular Dystrophy Dogs.
9. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.
10. Cardiomyopathy in the mouse model of Duchenne muscular dystrophy caused by disordered secretion of vascular endothelial growth factor.
11. Chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of duchenne muscular dystrophy.
12. Decreased gray matter concentration and local synchronization of spontaneous activity in the motor cortex in Duchenne muscular dystrophy.
13. Derivation of Engraftable Myogenic Precursors from Murine ES/iPS cells and Generation of Disease-specific iPS cells from Patients with Duchenne Muscular dystrophy (DMD) and Other Diseases.
14. Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy.
15. Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening.
16. Duchenne and Becker muscular dystrophy presenting as nonalcoholic fatty liver disease.
17. Duchenne or Becker muscular dystrophy: A clinical, genetic and immunohistochemical study in China.
18. Dystrophin dp71: the smallest but multifunctional product of the duchenne muscular dystrophy gene.
19. Effect of yoga and ayurveda on duchenne muscular dystrophy.
20. Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance.
21. Exon-skipping therapy for Duchenne muscular dystrophy.
22. Exon-skipping therapy for Duchenne muscular dystrophy.
23. Expression of collagen VI α5 and α6 chains in human muscle and in Duchenne muscular dystrophy-related muscle fibrosis.
24. Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: comprehensive mutational search in a single platform.
25. How should we monitor pediatric patients with Duchenne muscular dystrophy? -A case report-.
26. Identification of deletions and duplications in the Duchenne muscular dystrophy gene and female carrier status in western India using combined methods of multiplex polymerase chain reaction and multiplex ligation-dependent probe amplification.
27. Idiopathic intracranial hypertension in a child with Duchenne muscular dystrophy.
28. IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation.
29. Long-term Engraftment of Multipotent Mesenchymal Stromal Cells That Differentiate to Form Myogenic Cells in Dogs With Duchenne Muscular Dystrophy.
30. Low abdominal contribution to breathing as daytime predictor of nocturnal desaturation in adolescents and young adults with Duchenne Muscular Dystrophy.
31. Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments : Preliminary experience.
32. Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site.
33. Novel cationic carotenoid lipids as delivery vectors of antisense oligonucleotides for exon skipping in duchenne muscular dystrophy.
34. Nutrition strategies to improve physical capabilities in duchenne muscular dystrophy.
35. Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector.
36. Platelet m-calpain: a facile marker and STR polymorphism analysis for the identification of true carriers of Duchenne muscular dystrophy.
37. Prednisolone Treatment Does Not Interfere with 2'-O-Methyl Phosphorothioate Antisense-Mediated Exon Skipping in Duchenne Muscular Dystrophy.
38. Quantitative muscle ultrasound is a promising longitudinal follow-up tool in Duchenne muscular dystrophy.
39. R2 Predicting Scores for Left Ventricular Dysfunction in Duchenne Muscular Dystrophy.
40. Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy.
41. Sodium (23Na) MRI detects elevated muscular sodium concentration in Duchenne muscular dystrophy.
42. SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy: predicting the severity of Duchenne muscular dystrophy: implications for treatment.
43. Subjective caregiver burden of parents of adults with Duchenne muscular dystrophy.
44. Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.
45. The effect of Luque-Galveston fusion on curve, respiratory function and quality of life in Duchenne muscular dystrophy.
46. The neuropsychological profile of infantile Duchenne muscular dystrophy.
47. The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy.
48. Use of Complementary and Alternative Medicine by Males With Duchenne or Becker Muscular Dystrophy.
49. Use of skeletal muscle MRI in diagnosis and monitoring disease progression in duchenne muscular dystrophy.
50. Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS.